Serial No. 108-121: Emerging Threats: Assessing DoD Control of Surplus Chemical and Biological Equipment and Material: Hearing before the Subcommittee on National Security, Emerging Threats and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, First Session, October 7, 2003   [open pdf - 6MB]

Since the anthrax attacks of October 2001, much has been done to strengthen national defenses against biological warfare. Millions have been spent amassing pharmaceutical stockpiles, developing new antidotes and modernizing public health surveillance and response capacities. This hearing discusses the issues of legitimate military vendors providing bioterrorism equipment to the open public. "They provide a valuable service to DOD and the public, but the risk of biological terrorism has to be confronted openly and aggressively. Business as usual will not neutralize the potentially lethal combination of lax inventory management, nonexistent end use controls and weak accountability over the germs terrorists want to weaponize. Yes, much of this equipment can be acquired elsewhere. That may point to a much larger problem. But that portion of the problem attributable to the Department of Defense can be fixed. DOD should not be a discount outlet for bioterrorism equipment. Witnesses from GAO, the DOD Inspector General's office and the Department of Defense will describe the scope of these challenges and what can be done to reduce the risk of homegrown biological terrorism." Statements, letters, and materials submitted for the record include those of the following: Alan F. Estevez, Gregory Kutz, Frederick N. Baillie, Patrick E. O'Donnell, C.A. Ruppersberger, Christopher Shays, and Shelton Young.

Report Number:
Serial No. 108-121
Public Domain
Retrieved From:
Government Printing Office, Congressional Hearings: http://www.gpoaccess.gov/chearings/index.html
Media Type:
Help with citations